DCM
SRGA

Delpha Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Delpha Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-22
Closed -$3K – 1421
2017
Q4 		$3K Buy
+22
New +$3.02K ﹤0.01% 1445

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HC
Hillman Company Pittsburgh, Pennsylvania $283M AUM 23.82% 1-Year Est. Return
RCM
Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Delpha Capital Management's SRGA Position: Q1 2018 in Review

Delpha Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q1 2018, closing a stake of 22 shares — an estimated $3K sold.

Delpha Capital Management first reported a position in SRGA in Q4 2017 and held it in 1 quarter. The position peaked at $3K in Q4 2017. 109 funds tracked by Wall St. Rank hold SRGA as of Q1 2018.

  • Delpha Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 22 Surgalign Holdings, Inc. Common Stock shares in Q1 2018, an estimated $3K.
  • Delpha Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $3K in Q4 2017.
  • 109 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.